HeraMED opens with steady rhythm.

Investors were listening closely today as pregnancy monitoring solutions provider HeraMED (HMD) began trade at 1pm.

Currently known best for its HeraBEAT product, HeraMED encountered a number of delays before making its way to the ASX and unfortunately the overdue arrival did not post any significant gains first up.

HeraMED will use funds from the IPO for all the usual things, including product development, and despite only trading for the same 20 cents ask as the the IPO, there’s still a good 25M+ on hand to play with.

With some of the products in development, we’re expecting this one to do better down the track making it a nice little incubator to add to your portfolio.